martes, 29 de agosto de 2017

ACR Appropriateness Criteria® monitoring response to neoadjuvant systemic therapy for breast cancer. | National Guideline Clearinghouse

ACR Appropriateness Criteria® monitoring response to neoadjuvant systemic therapy for breast cancer. | National Guideline Clearinghouse

ngc

American College of Radiology




  • GUIDELINE SUMMARY
    •  
  • NGC:011204
    •  
  • 2017

ACR Appropriateness Criteria® monitoring response to neoadjuvant systemic therapy for breast cancer.

en

No hay comentarios:

Publicar un comentario